39479311000001102: Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)
\UK product\Virtual medicinal product\Trastuzumab deruxtecan 100mg powder for solution for infusion vials\Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)
\UK product\Virtual therapeutic moiety\Trastuzumab deruxtecan\Trastuzumab deruxtecan 100mg powder for solution for infusion vials\Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)
\UK product\Trade family\Enhertu\Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab deruxtecan (medicinal product)\Trastuzumab deruxtecan\Trastuzumab deruxtecan 100mg powder for solution for infusion vials\Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing trastuzumab deruxtecan (medicinal product)\Trastuzumab deruxtecan\Trastuzumab deruxtecan 100mg powder for solution for infusion vials\Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab deruxtecan (medicinal product)\Trastuzumab deruxtecan\Trastuzumab deruxtecan 100mg powder for solution for infusion vials\Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab deruxtecan (medicinal product)\Trastuzumab deruxtecan\Trastuzumab deruxtecan 100mg powder for solution for infusion vials\Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab deruxtecan (medicinal product)\Trastuzumab deruxtecan\Trastuzumab deruxtecan 100mg powder for solution for infusion vials\Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Apr 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

619781000001114 Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

619791000001111 Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)	Has excipient	Polysorbate	false	Inferred relationship	Existential restriction modifier
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)	Is a	Trastuzumab deruxtecan 100mg powder for solution for infusion vials	true	Inferred relationship	Existential restriction modifier
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator	EMA (European Medicines Agency) monitoring	true	Inferred relationship	Existential restriction modifier
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)	Is a	Enhertu	true	Inferred relationship	Existential restriction modifier
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)	Has dispensed dose form	Powder for conventional release solution for infusion	true	Inferred relationship	Existential restriction modifier
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	false	Inferred relationship	Existential restriction modifier
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)	Has specific active ingredient	Trastuzumab deruxtecan	true	Inferred relationship	Existential restriction modifier
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)	VMP prescribing status (attribute)	Caution - AMP level prescribing advised	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd) 1 vial	Has AMP	True	Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
619781000001114	Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
619791000001111	Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module